(19)
(11) EP 1 531 833 A1

(12)

(43) Date of publication:
25.05.2005 Bulletin 2005/21

(21) Application number: 03738866.7

(22) Date of filing: 17.07.2003
(51) International Patent Classification (IPC)7A61K 31/7088, A61K 48/00, A61P 11/06, A61P 17/06, A61P 11/00, A61P 19/02, A61P 1/04, A61P 1/00, C12N 15/11
// (C12N9/64, 9:66)
(86) International application number:
PCT/SE2003/001223
(87) International publication number:
WO 2004/009098 (29.01.2004 Gazette 2004/05)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 18.07.2002 SE 0202253
04.09.2002 US 407680 P

(71) Applicant: Index Pharmaceuticals AB
171 77 Stockholm (SE)

(72) Inventors:
  • DIECKMANN, Andreas
    S-167 36 Bromma (SE)
  • LÖFBERG, Robert
    S-182 55 Djursholm (SE)
  • VON STEIN, Oliver
    S-163 41 Sp nga (SE)
  • VON STEIN, Petra
    S-163 41 Sp nga (SE)
  • GOOD, Liam
    SE-113 60 Stockholm (SE)

(74) Representative: Holmberg, Martin et al
Bergenstrahle & Lindvall ABP.O. Box 17704
118 93 Stockholm
118 93 Stockholm (SE)

   


(54) ANTISENSE COMPOUNDS, METHODS AND COMPOSITIONS FOR TREATING MMP-12 RELATED INFLAMMATORY DISORDERS